uniQure N.V.
NASDAQ:QUREBiotechnology
Healthcare
$20.23 -2.34%
-$1.13 today
- Market cap
- $1.42B
- Beta
- 1.00
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$3.33
52W Low $8.73High $71.50
Volume 1.16M
Average 1.75M
Income Statement
Follow revenue through to earnings.
Revenue
$16.10M
FY 2025 · Annual
-40.6% YoYOperating Income
-$187.83M
FY 2025 · Annual
Net Income
-$198.97M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 524M | 106.48M | 15.84M | 27.12M | 16.1M |
| Cost of Revenue | 24.98M | 3.34M | 13.63M | 18.33M | 1.69M |
| Gross Profit | 499.03M | 103.14M | 2.22M | 8.79M | 14.41M |
| Gross Margin | 95.2% | 96.9% | 14.0% | 32.4% | 89.5% |
| Research & Development | 143.55M | 197.59M | 214.86M | 143.78M | 140.67M |
| Selling, General & Admin | 56.29M | 54.7M | 73.08M | 50.68M | 65.34M |
| Operating Expenses | 188.41M | 246.3M | 285.09M | 193.09M | 202.24M |
| Depreciation & Amortization | 7.3M | 8.54M | 11.9M | 12.64M | 14.76M |
| EBITDA | 319M | (108.02M) | (253.1M) | (160.75M) | (116.59M) |
| EBITDA Margin | 60.9% | -101.4% | -1597.6% | -592.7% | -724.2% |
| Operating Income | 310.62M | (143.16M) | (282.87M) | (184.29M) | (187.83M) |
| Operating Margin | 59.3% | -134.4% | -1785.5% | -679.6% | -1166.8% |
| Interest Income | 162K | 609K | 19.56M | 21.42M | 16.97M |
| Interest Expense | 7.47M | 11.7M | 41.56M | 63.74M | 61.99M |
| Other Income / Expenses | 22.19M | 14.9M | (23.69M) | (52.83M) | (5.51M) |
| Income Before Tax | 332.81M | (128.26M) | (306.56M) | (237.13M) | (193.34M) |
| Pre-Tax Margin | 63.5% | -120.5% | -1935.0% | -874.4% | -1201.0% |
| Income Tax Expense | 3.22M | (1.47M) | 1.92M | 2.43M | 5.63M |
| Net Income | 329.59M | (126.79M) | (308.48M) | (239.56M) | (198.97M) |
| Net Margin | 62.9% | -119.1% | -1947.1% | -883.4% | -1236.0% |
| EPS (Basic) | 7.17 | (2.71) | (6.47) | (4.92) | (3.46) |
| EPS (Diluted) | 7.04 | (2.71) | (6.47) | (4.92) | (3.46) |
| 45.99M | 46.74M | 47.67M | 48.65M | 57.5M | |
| 46.84M | 46.74M | 47.67M | 48.65M | 57.5M |
QURE Earnings Waterfall · TTM
NASDAQ:QURE · Revenue to Net Income
Key Ratios
EPS$-3.51
Gross Margin77.4%
Net Margin-1265.4%
P/E Ratio-7.6
P/S Ratio400.8
Analysis
$18.1M of revenue converted into -$208.9M of net income for the selected period. Gross margin is 77.4% and net margin is -1265.4%, showing how much revenue survives after costs and taxes. EPS is $-3.51, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 10, 2026 | |
| 8-K | Current report | Nov 4, 2026 | |
| 10-Q | Quarterly report | Nov 4, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 3, 2026 | |
| 8-K | Current report | Nov 2, 2026 |
How much revenue does QURE generate?
uniQure N.V. (QURE) reported $16.10M of revenue in fiscal 2025.
Is QURE profitable?
uniQure N.V. (QURE) reported -$198.97M of net income, with a net margin of -1236.0%.
Continue the stock analysis
Jump to another research area for this company.